K050755 is an FDA 510(k) clearance for the MODIFICATION TO BVBLUE. Classified as Test, Vaginal, Bacterial Sialidase (product code MXB), Class I - General Controls.
Submitted by Gryphus Diagnostics, LLC (Rockville, US). The FDA issued a Cleared decision on April 6, 2005 after a review of 14 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 866.2660 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.